Literature DB >> 28465264

Quantitative Susceptibility Mapping as a Possible Tool to Radiographically Diagnose Sentinel Headache Associated with Intracranial Aneurysm: Case Report.

Daichi Nakagawa1, Cameron Cushing2, Yasunori Nagahama2, Lauren Allan3, David Hasan4.   

Abstract

BACKGROUND: Sentinel headache (SH) occurs before aneurysm rupture in an estimated 15%-60% of cases of aneurysmal subarachnoid hemorrhage (aSAH). By definition, noncontrast computed tomography (CT) scan of the brain and lumbar puncture are both negative in patients presenting with SH. One of the theories explaining this phenomenon is that microhemorrhage (MH) from the aneurysm wall contribute to iron deposition in the interface between the aneurysm wall and brain parenchyma. Quantitative susceptibility mapping (QSM) is a recently introduced magnetic resonance imaging (MRI) technique that has proven capable of localizing the deposition of paramagnetic metals, particularly ferric iron. Thus, the QSM sequence may be able to detect iron deposition secondary to MH. CASE DESCRIPTION: A 76-year-old male presented with the "worst headache of my life." Noncontrast head CT scan and lumbar puncture were negative. Magnetic resonance angiography (MRA) of the brain revealed an anterior communicating artery (A-com) aneurysm measuring 7 mm with a large bleb. T1-weighted imaging (WI), T2-WI, MRA, T2 star-weighted angiography (SWAN), and QSM sequences were obtained. T2-WI, SWAN, and QSM revealed isointense, hypointense, and hyperintense signals, respectively, at the interface of the aneurysm wall and brain tissue. These findings were consistent with deposition of ferric iron at this interface. The A-com aneurysm was treated with coil embolization, and the patient exhibited no postoperative deficits.
CONCLUSIONS: The MRI QSM sequence can localize iron deposition resulting from MH within an aneurysmal wall. This sequence may be a promising imaging tool for screening patients presenting with SH.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aneurysm; Magnetic resonance imaging; Microhemorrhage; Quantitative susceptibility mapping; Sentinel headache; Subarachnoid hemorrhage; Susceptibility weighted imaging

Mesh:

Year:  2017        PMID: 28465264     DOI: 10.1016/j.wneu.2017.04.151

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  5 in total

1.  Detection of microbleeds associated with sentinel headache using MRI quantitative susceptibility mapping: pilot study.

Authors:  Daichi Nakagawa; Kohsuke Kudo; Olatilewa Awe; Mario Zanaty; Yasunori Nagahama; Cameron Cushing; Vincent Magnotta; Minako Hayakawa; Lauren Allan; Jeremy Greenlee; Issam A Awad; Timothy Carroll; James Torner; Madhavan L Raghavan; David M Hasan
Journal:  J Neurosurg       Date:  2018-05-01       Impact factor: 5.115

2.  Clinical characteristics associated with sentinel headache in patients with unruptured intracranial aneurysms.

Authors:  Zheng Wan; Hao Meng; Ning Xu; Tianyi Liu; Zhongping Chen; Yang Sun; Honglei Wang
Journal:  Interv Neuroradiol       Date:  2020-11-04       Impact factor: 1.764

Review 3.  Unruptured cerebral aneurysm risk stratification: Background, current research, and future directions in aneurysm assessment.

Authors:  Michael A Silva; Stephanie Chen; Robert M Starke
Journal:  Surg Neurol Int       Date:  2022-04-29

4.  Quantitative Susceptibility Mapping and Vessel Wall Imaging as Screening Tools to Detect Microbleed in Sentinel Headache.

Authors:  Daizo Ishii; Daichi Nakagawa; Mario Zanaty; Jorge A Roa; Sami Al Kasab; Amir Shaban; Joseph S Hudson; Carlos Osorno-Cruz; Stefano Byer; Lauren Allan; James C Torner; Issam A Awad; Timothy J Carroll; Edgar A Samaniego; David M Hasan
Journal:  J Clin Med       Date:  2020-04-01       Impact factor: 4.241

5.  Warning Signs in the Era of Unruptured Intracranial Aneurysms: Report on 2 Cases of Fatal Aneurysmal Hemorrhage.

Authors:  Katarzyna Wójtowicz; Przemysław Kunert; Łukasz Przepiórka; Andrzej Marchel
Journal:  Cerebrovasc Dis Extra       Date:  2021-07-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.